Vascular access devices market seen reaching $8.38 billion by 2030

The Business Research Company says the global vascular access devices market will grow from $6.11 billion in 2025 to $6.51 billion in 2026, driven by more chronic disease, more intravenous procedures and wider use of catheters and implantable ports. North America led the market in 2025, while Asia-Pacific is projected to grow fastest through 2030.

Why it matters: - Vascular access devices are central to delivering medications, fluids, blood products and diagnostic testing. - Demand is rising as chronic disease, oncology care and infusion therapy require more reliable venous access. - The market outlook points to continued spending on safer, more patient-friendly catheter systems.

What happened: - The Business Research Company published a vascular access devices market report covering market size, trends and global forecasts for 2026-2035. - The market is expected to rise from $6.11 billion in 2025 to $6.51 billion in 2026. - The report projects the market will reach $8.38 billion by 2030.

The details: - The 2026 forecast implies 6.6% annual growth, while the 2030 projection uses a 6.5% CAGR. - Growth is tied to more chronic disease cases requiring long-term infusion therapy. - Higher volumes of intravenous procedures in hospitals and clinics are adding demand. - Central venous catheters and peripherally inserted central catheters, or PICC lines, are seeing wider use. - Diagnostic testing and blood transfusions are expanding the addressable market. - Peripheral intravenous catheters remain important in acute care settings. - The report also points to rising adoption of implantable ports, especially in oncology and long-duration therapies. - Vascular access services are expanding in ambulatory care centers. - More drug and nutrition administration procedures are supporting growth. - Investment in safer catheter designs is aimed at reducing complications. - The report highlights greater use of long-term vascular access devices for chronic conditions. - Demand is rising for products that reduce repeated needle punctures. - Specialized catheters are increasingly used for chemotherapy, infusion therapy and blood administration. - The report says North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period. - The regional analysis also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The report includes market attractiveness scoring, TAM analysis, company scoring matrices, Excel-based forecasting dashboards, market hotspot infographics and updated graphics and tables. - The report offers a free sample and full report online through the company’s website: Download a free sample and View the full market report.

Between the lines: - The report frames vascular access devices as a steady-growth category rather than a breakout market. - The strongest demand drivers are structural: chronic illness prevalence, recurring procedures and the push to reduce treatment discomfort. - The regional split suggests mature demand in North America and faster expansion in emerging and cost-sensitive Asian markets.

What's next: - Market growth is likely to track chronic disease prevalence and procedure volumes in hospitals, clinics and ambulatory care centers. - Product competition appears set to focus on comfort, safety and lower complication risk. - The report expects continued momentum for minimally invasive venous access options through 2030.